Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Aspartate transcarbamylase (ATCase) is a key allosteric enzyme that catalyzes the first committed step in the biosynthesis of pyrimidine nucleotides. This reaction is essential for the production of DNA and RNA building blocks in cells. ATCase catalyzes the condensation of L-aspartate and carbamoyl phosphate to form N-carbamoyl-L-aspartate and inorganic phosphate. The enzyme’s activity is tightly regulated by feedback inhibition from cytidine triphosphate (CTP) and activated by ATP. ATCase is a dodecamer composed of 12 subunits: six catalytic chains arranged into two trimers at the core, surrounded by three regulatory dimers. It exists in equilibrium between two conformational states: Tense (T) and Relaxed (R). The transition between these states underlies both cooperativity among active sites and allosteric regulation by nucleotides.
Inhibition of enzymatic activity; allosteric modulation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Aspartate transcarbamylase (ATCase).